每步都算数:成人内科住院患者活动能力与静脉血栓栓塞风险的增量关系
BACKGROUND: Hospital-associated venous thromboembolism (VTE) is a leading but preventable cause of morbidity and mortality.…
要点
- 活动能力越低,VTE发生率越高,呈剂量反应关系
- 每1000患者日VTE事件数从JH-HLM 8级的0.064升至1级的0.195
核心结论
- 住院患者活动能力越低,VTE发生率呈剂量反应式升高,且独立于药物预防。
- 当前风险模型将活动能力二分化存在局限,支持将客观活动评估纳入预防策略。
研究设计与样本
- 回顾性队列研究,2021-2024年,纳入2家学术医疗中心的成人内科住院患者。
- 每日JH-HLM评分取连续3天平均值,定义时间变化的活动能力暴露。
- 主要结局为同次住院期间首次影像学确诊的症状性VTE。
- 采用合并泊松回归模型分析时间变化活动能力与后续VTE率的关系,调整住院日、人口学、合并症、除活动能力外的Padua要素、支付方和预防状态。
主要发现
- 3天平均JH-HLM为8级(步行≥250英尺)时,VTE率为0.064事件/1000患者日。
- 3天平均JH-HLM为6级(步行≥10步)时,VTE率为0.088事件/1000患者日。
- 3天平均JH-HLM为4级(移至椅子/便桶)时,VTE率为0.121事件/1000患者日。
- 3天平均JH-HLM为1级(卧床)时,VTE率为0.195事件/1000患者日。
临床怎么用
- 对内科住院患者应动态评估活动能力,而非仅二分类判断。
- 低活动能力患者即使接受药物预防,VTE风险仍随活动能力下降而升高。
- 可考虑将客观活动能力评估整合进VTE预防策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hospital-associated venous thromboembolism (VTE) is a leading but preventable cause of morbidity and mortality. Immobility is a key risk factor, yet commonly used scores such as Padua treat it as binary and static, overlooking the physiological and temporal continuum of mobility. The Johns Hopkins Highest Level of Mobility (JH-HLM) scale captures 8 milestones across this continuum. OBJECTIVES: We investigated whether lower JH-HLM levels are associated with progressively higher VTE rates and whether this relationship differs by prescribed pharmacologic prophylaxis. METHODS: We conducted a retrospective cohort study (2021-2024) of adult medicine inpatients admitted to 2 academic medical centers. Daily JH-HLM scores were averaged over 3 consecutive hospital days to define a time-varying mobility exposure. The primary outcome was first radiologically confirmed, symptomatic VTE during the same admission. A pooled Poisson regression model correlated time-varying mobility with subsequent VTE rates, adjusting for day of hospitalization, demographics, comorbidities, Padua elements (excluding mobility), payer, and prophylaxis status. RESULTS: Among 25 763 patients, 169 developed VTE (0.7%). VTE rates increased stepwise with lower preceding mobility (P = .001): 0.064, 0.088, 0.121, and 0.195 events per 1000 patient-days when preceded by a 3-day average JH-HLM of level 8 (walk ≥250 feet), 6 (walk ≥10 steps), 4 (move to chair/commode), and 1 (lying in bed), respectively. This relationship did not differ by prescribed chemoprophylaxis (P = .37). CONCLUSION: Lower inpatient mobility conferred a dose-response increase in VTE rates independent of prophylaxis. These findings highlight limitations of binary mobility items in current risk models and support integrating objective mobility assessments into prevention strategies.
引用
- Hoyer EH, Brotman DJ, Young DL, et al. Every step counts: incremental mobility and venous thromboembolism risk among adult general medicine inpatients. J Thromb Haemost. 2026. PMID: 42731731. doi:10.1016/j.jtha.2026.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。